<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104002">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01650961</url>
  </required_header>
  <id_info>
    <org_study_id>YSJeon_palonosetron_QTc</org_study_id>
    <nct_id>NCT01650961</nct_id>
  </id_info>
  <brief_title>The Effect of Palonosetron on the QTc Interval During Perioperative Period</brief_title>
  <official_title>The Effect of Palonosetron on the QTc Interval During Perioperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effects of palonosetron on corrected QT interval
      duration during and after general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>corrected QT interval (QTc interval)</measure>
    <time_frame>up to 90 minutes after induction of general anesthesia</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>at 2, 10, 15, 30, 60, 90 minutes after induction of general anesthesia, up to 1 minute after tracheal intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>proportion of patients whose corrected QT interval (QTc interval) is more than 450 ms for male or 470 ms for female</measure>
    <time_frame>up to 2 hours after induction of general anesthesia</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>corrected QT interval (QTc interval) at Postanesthetic care unit</measure>
    <time_frame>up to 1 hour after arrival on postanesthetic care unit</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea and vomiting</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of patients who have more than 500 ms of corrected QT interval (QTc interval)</measure>
    <time_frame>up to 2 hours after induction of general anesthesia</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Anesthesia, General</condition>
  <condition>Palonosetron</condition>
  <arm_group>
    <arm_group_label>Palonosetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous administration of palonosetron 0.075 mg before the induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous administration of normal saline before the induction of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Palonosetron</intervention_name>
    <description>0.075 mg IV as bolus before induction of general anesthesia</description>
    <arm_group_label>Palonosetron</arm_group_label>
    <other_name>Aloxi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>2 ml normal saline as bolus before induction of general anesthesia</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective abdominal surgery under general anesthesia

        Exclusion Criteria:

          -  Cardiac valvular disease

          -  Clinically significant arrhythmias including atrial fibrillation

          -  Anti-emetics within 24 hours before surgery

          -  Steroids within 1 week before surgery

          -  Cancer chemotherapy or radiotherapy within 4 weeks before surgery

          -  Diabetes mellitus

          -  Pregnancy

          -  Patients receives a QT-prolonging drug
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 6, 2013</lastchanged_date>
  <firstreceived_date>July 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Palonosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
